SPY765.90−0.17%QQQ739.41−0.23%BTC/USD84,237.07−0.18%DIA511.90−0.15%GLD391.02−0.17%TLT79.52+0.13%
Benzinga

Allarity Therapeutics Inc (ALLR) Stock Price, Quote, News & History

ALLRNASDAQ
Trade with Public
Trade with Public
$1.09
0.054.81%
At close: Sep 24, 5:00 PM EST
$1.09
-0.0001-0.01%
After Hours: 4:50 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentCompareStock Report

Allarity Therapeutics (ALLR) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$1.06
Close
$1.09
Volume / Avg.
74.98K / 100.40K
Day Range
$1.03 - $1.09
52 Wk Range
0.77 - 1.84
Market Cap
$17.34M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
0.75%
Days to Cover
1.58

Recent Allarity Therapeutics Inc News

Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket

Lobo Technologies shares surged 32% premarket after a narrower H1 loss and higher sales; several small caps rallied while others fell sharply.
Avi Kapoor

Rapport Therapeutics To Rally Around 76%? Here Are 10 Top Analyst Forecasts For Wednesday

Analysts raised targets for RAPP, ALLR, UNP and ALVO; cut targets for NU, CLLS and JBHT, with several rating upgrades and downgrades.
Avi Kapoor

Crude Oil Down 2%; US Durable Goods Orders Decline In July

Avi Kapoor

US Stocks Mixed; American Woodmark Posts Downbeat Sales

Avi Kapoor

Stock Market Today: Nasdaq 100 Futures Slip— Palo Alto, XP, Allarity Earnings In Focus (UPDATED)

U.S. stock futures slipped on Monday following Friday's mixed moves. Futures of major benchmark indices were lower.
Rishabh Mishra

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-13.71M
Investing Cash Flow (TTM)
-72.00K
Financing Cash Flow (TTM)
21.81M
Free Cash Flow (TTM)
-13.78M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
8.03M

Analyst Trends and Forecast

1
Apr
1
Jun
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$22.65M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
49.52
PB Ratio (TTM)
4.90
Earnings Yield % (TTM)
-72.48%
Earnings Yield % (FWD)
-78.90%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.22

Company Debt

Total Debt
$22.29M
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$16.98M
Debt to Equity
6.30
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.06
Close
$1.09
Volume / Avg.
74.98K / 100.40K
Day Range
$1.03 - $1.09
52 Wk Range
0.77 - 1.84
Market Cap
$17.34M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
0.75%
Days to Cover
1.58

About

Sector
Health Care
Industry
Biotechnology
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib,...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Allarity Therapeutics (ALLR) stock?

A

You can purchase shares of Allarity Therapeutics (NASDAQ:ALLR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Allarity Therapeutics (ALLR) competitors?

Q

What is the forecast, or price target, for Allarity Therapeutics (ALLR) stock?

A

Allarity Therapeutics has a consensus price target of $11.00.

Q

What is the current price for Allarity Therapeutics (ALLR)?

A

The stock price for Allarity Therapeutics (NASDAQ: ALLR) is $1.0899 last updated September 24, 2026 at 4:50 PM EDT.

Q

Does Allarity Therapeutics (ALLR) pay a dividend?

A

There are no upcoming dividends for Allarity Therapeutics.

Q

When is Allarity Therapeutics (NASDAQ:ALLR) reporting earnings?

A

Allarity Therapeutics does not have any upcoming earnings scheduled.

Q

Is Allarity Therapeutics (ALLR) going to split?

A

There is no upcoming split for Allarity Therapeutics.

Q

What sector and industry does Allarity Therapeutics (ALLR) operate in?

A

Allarity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved